The current pharma/bio market is a rapidly growing, high innovation market that has maintained exceptional growth over the past several years. Of the many technologies that have benefited from its rapid expansion, mass spectrometry has been at the forefront. The adoption of mass spectrometers has been particularly swift in proteomics and metabolomics applications. There are […]
Author Archive for: wesbova
About Wes Bova
This author has not written his bio yet.
But we are proud to say that Wes Bova contributed 3 entries already.
Entries by Wes Bova
Commercial testing labs play an important role in administering specialized environmental testing, with clients ranging from governmental agencies to corporate entities looking to meet regulatory burdens, health standards and to improve their environmental footprint. During the pandemic, these labs faced hardships as public and corporate funding was curtailed, impacting the overall environmental testing market. Now, […]
Clinical laboratory diagnostics has become an important area of investment and business transactions. Recently, Mesa Laboratories, a biotech company focused on quality control solutions for pharmaceutical, healthcare, and medical devices, announced the acquisition of Agena Bioscience for a cash purchase price of $300 million. According to the press release, Mesa is expected to pay for […]
June 14, 2021 1:52 pm
April 27, 2021 7:19 am
Strategic Directions International (SDi), part of Science and Medicine Group, is the leading business intelligence firm in the highly specialized field of analytical and life science instruments. Its client list includes virtually every major analytical instrumentation company in the United States, Europe, and Japan. Founded in 1981, the Los Angeles-based company has published hundreds of market reports and provided proprietary consulting services for a multitude of clients.